✦ LIBER ✦

Age and the treatment of lung cancer.

✍ Scribed by Brown, J S; Eraut, D; Trask, C; Davison, A G

Book ID: 127044182
Publisher: BMJ Publishing Group
Year: 1996
Tongue: English
Weight: 933 KB
Volume: 51
Category: Article
ISSN: 0040-6376
DOI: 10.1136/thx.51.6.564

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non–Small Cell Lung Cancer at the Extrem

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment

✍ William C Nugent; MD; Mark T Edney; BA; Paul G Hammerness; BA; Bradley J Dain; P 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 192 KB

P-762 Limited small cell lung cancer (LS

P-762 Limited small cell lung cancer (LSCLC) — observations from the National Cancer Database on the impact of age, gender and treatment on survival

✍ Gaspar, L.; Gay, G.; Crawford, J.; Putnam, J.; Herbst, R.; Bonner, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

82 A retrospective cohort study analysin

82 A retrospective cohort study analysing the differences in care and treatment of patients with lung cancer based on age

✍ Ratnayake, G.; Sawicka, E. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Influence of age, comorbidity and perfor

Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study

✍ de Rijke, J.M.; Schouten, L.J.; Velde, G.P.M.ten; Wanders, S.L.; Bollen, E.C.M.; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

1097 The influence of sex, age and histo

1097 The influence of sex, age and histology on treatment results of radically treated patients with locally advanced, non-small cell lung cancer radiated with curative intent

✍ Jovanovski, D.; Smickoska, S.; Crvenova, S. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase 2 trial of docetaxel and gefitinib

Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older

✍ George R. Simon; Martine Extermann; Alberto Chiappori; Charles C. Williams; Mube 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

## Abstract ## BACKGROUND This is a phase 2 study of chemotherapy‐naive patients, 70 years of age or older, with nonsmall‐cell lung cancer (NSCLC) who were treated with docetaxel and gefitinib. The primary endpoint was response rate (RR). Secondary endpoints were overall survival (OS) and progress